| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 406.00K | — |
| Operating expense | — | — |
| Net income | -22.83M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IMMNOV.ST returned -71.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.7% |
| 1 year | -71.9% |
| 5 years | -99.7% |
| 10 years | -99.6% |
| All-time high | kr 93.56 (Sep 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in IMMNOV.ST would be worth today ›No. Immunovia AB (publ) has not paid a dividend in the past 12 months.
Immunovia AB (publ) is part of the Healthcare sector.
Immunovia AB (publ) has a market cap of 102.78M SEK, based on the latest quote.
